Lornidase P Tablet is a combination of three medicines: Lornoxicam, Paracetamol / Acetaminophen and Serratiopeptidase which relieve pain. Lornoxicam is a non-steroidal antiinflammatory drug (NSAID) and Paracetamol / Acetaminophen is an antipyretic (fever reducer). They work by blocking the release of certain chemical messengers in the brain that cause pain and fever. Serratiopeptidase is an enzyme which works by breaking down abnormal proteins at the site of inflammation, and promotes healing.
Taking Lornoxicam+Paracetamol / Acetaminophen+Serratiopeptidase with alcohol can cause liver damage.
WEIGH RISKS VS BENEFITS
Lornidase P Tablet is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
No information is available on the use of Lornidase P Tablet during lactation. Please consult your doctor.
Lornidase P Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Lornidase P Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Lornidase P Tablet may not be needed in these patients. Please consult your doctor.
Lornidase P Tablet should be used with caution in patients with liver disease. Dose adjustment of Lornidase P Tablet may be needed. Please consult your doctor. However, the use of Lornidase P Tablet is not recommended in patients with severe liver disease and active liver disease.